ConductScience.org, home

Paper41988186

Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review.

Fu X and 3 others. Front Immunol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review. Papers, record 41988186. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41988186

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review.
PubMed
Journal
Front Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Case Reports, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fu XXiaoJuan
2Gao FFang
3Zang LLi
4Mao NNan

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glomerulonephritis, MembranousMajor topic
Sjogren's SyndromeMajor topic
RituximabMajor topic
Immunologic FactorsMajor topic
Humans
Female
Middle Aged
Treatment Outcome

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119571279M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.N Engl J Med2009https://conductscience.org/library/papers/19571279PubMed
228099084Mechanisms and New Strategies for Primary Sjögren's Syndrome.Annu Rev Med2017https://conductscience.org/library/papers/28099084PubMed
328610655The Diagnosis and Treatment of Sjögren's Syndrome.Dtsch Arztebl Int2017https://conductscience.org/library/papers/28610655PubMed
429401359Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key points.Nephrol Dial Transplant2018https://conductscience.org/library/papers/29401359PubMed
523196797Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies.Mod Pathol2013https://conductscience.org/library/papers/23196797PubMed
633367966Renal Disease in Primary Sjögren's Syndrome.Rheumatol Ther2021https://conductscience.org/library/papers/33367966PubMed
723328976IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression.Mod Pathol2013https://conductscience.org/library/papers/23328976PubMed
819487655A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.Neurology2009https://conductscience.org/library/papers/19487655PubMed
922146604The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease.Mult Scler2012https://conductscience.org/library/papers/22146604PubMed
1025897541Efficacy of retreatment with rituximab in patients with primary Sjögren's syndrome.Clin Exp Rheumatol2015https://conductscience.org/library/papers/25897541PubMed
1131672775EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.Ann Rheum Dis2020https://conductscience.org/library/papers/31672775PubMed
1220131246Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.Arthritis Rheum2010https://conductscience.org/library/papers/20131246PubMed
1316253713Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with Sjögren syndrome.Am J Kidney Dis2005https://conductscience.org/library/papers/16253713PubMed
1411733624Clinical and morphological features of kidney involvement in primary Sjögren's syndrome.Nephrol Dial Transplant2001https://conductscience.org/library/papers/11733624PubMed
1528550082Primary Membranous Nephropathy.Clin J Am Soc Nephrol2017https://conductscience.org/library/papers/28550082PubMed
1621527186Primary Sjögren's syndrome with minimal change disease--a case report.Kaohsiung J Med Sci2011https://conductscience.org/library/papers/21527186PubMed
1726092914International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.Neurology2015https://conductscience.org/library/papers/26092914PubMed
1825916811ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review.Autoimmun Rev2015https://conductscience.org/library/papers/25916811PubMed
1925760364Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.N Engl J Med2015https://conductscience.org/library/papers/25760364PubMed
2024566651Sjögren syndrome.CMAJ2014https://conductscience.org/library/papers/24566651PubMed

See all 41 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41988186

GET https://conductscience.org/api/papers/v1/41988186/references?page=2